Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways

Circulation Research

Volumn 119, Issue 8, 2016, Pages 921-930

  Hatzistergos, Konstantinos E ^a   Saur, Dieter ^b,c   Seidler, Barbara ^b,c   Balkan, Wayne ^a   Breton, Matthew ^a   Valasaki, Krystalenia ^a   Takeuchi, Lauro M ^a   Landin, Ana Marie ^a   Khan, Aisha ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

coculture techniques; CXCR4; mesenchymal stromal cells; myocytes, cardiac; receptors; stem cell factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHEMOKINE RECEPTOR CXCR4; ENHANCED GREEN FLUORESCENT PROTEIN; PLERIXAFOR; RED FLUORESCENT PROTEIN; STEM CELL FACTOR; TAMOXIFEN; TRANSCRIPTION FACTOR NKX2.5; TROPOMYOSIN; CXCR4 PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ALLELE; ANIMAL CELL; ARTICLE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; COCULTURE; CONGESTIVE CARDIOMYOPATHY; EPICARDIUM; EXPLANT; FEEDER CELL; FLOW CYTOMETRY; HEART VALVE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MESENCHYMAL STEM CELL; MOUSE; MUSCLE DEVELOPMENT; NEURAL CREST CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CLINICAL TRIAL; CONTROLLED STUDY; MESENCHYMAL STROMA CELL; METABOLISM; NEWBORN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; PIG; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STEM CELL FACTOR; SWINE;

EID: 84982845816     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309281     Document Type: Article

References (46)

1. Anversa P, Kajstura J, Rota M, Leri A, Regenerating new heart with stem cells. J Clin Invest 2013 123 62 70. doi: 10.1172/JCI63068
2. van Berlo JH, Molkentin JD, An emerging consensus on cardiac regeneration. Nat Med 2014 20 1386 1393. doi: 10.1038/nm.3764
3. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, Middleton RC, Marbán E, Molkentin JD, c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 2014 509 337 341. doi: 10.1038/nature13309
4. Hatzistergos KE, Takeuchi LM, Saur D, Seidler B, Dymecki SM, Mai JJ, White IA, Balkan W, Kanashiro-Takeuchi RM, Schally AV, Hare JM, cKit+ cardiac progenitors of neural crest origin. Proc Natl Acad Sci U S A 2015 112 13051 13056. doi: 10.1073/pnas.1517201112
5. Sultana N, Zhang L, Yan J, Chen J, Cai W, Razzaque S, Jeong D, Sheng W, Bu L, Xu M, Huang GY, Hajjar RJ, Zhou B, Moon A, Cai CL, Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat Commun 2015 6 8701. doi: 10.1038/ncomms9701
6. Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, Tian X, Nie Y, Hu S, Yan Y, Zhang L, Qiao Z, Wang QD, Lui KO, Zhou B, Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res 2016 26 119 130. doi: 10.1038/cr.2015.143
7. Karantalis V, Suncion-Loescher VY, Bagno L, Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 2015 66 1990 1999. doi: 10.1016/j.jacc.2015.08.879
8. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM, Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013 127 213 223. doi: 10.1161/CIRCULATIONAHA.112.131110
9. Hatzistergos KE, Quevedo H, Oskouei BN, Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010 107 913 922. doi: 10.1161/CIRCRESAHA.110.222703
10. Quijada P, Salunga HT, Hariharan N, Cubillo JD, El-Sayed FG, Moshref M, Bala KM, Emathinger JM, De La Torre A, Ormachea L, Alvarez R Jr, Gude NA, Sussman MA, Cardiac stem cell hybrids enhance myocardial repair. Circ Res 2015 117 695 706. doi: 10.1161/CIRCRESAHA.115.306838
11. Avolio E, Meloni M, Spencer HL, Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res 2015 116 e81 e94. doi: 10.1161/CIRCRESAHA.115.306146
12. Hatzistergos KE, Hare JM, Murine models demonstrate distinct vasculogenic and cardiomyogenic cKit+ lineages in the heart. Circ Res 2016 118 382 387. doi: 10.1161/CIRCRESAHA.115.308061
13. Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, Parker M, Dermarkarian CR, DiFede DL, Balkan W, Khan A, Hare JM, Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells. EBioMedicine 2015 2 467 475. doi: 10.1016/j.ebiom.2015.03.020
14. Isern J, García-García A, Martín AM, Arranz L, Martín-Pérez D, Torroja C, Sánchez-Cabo F, Méndez-Ferrer S, The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. Elife 2014 3 e03696. doi: 10.7554/eLife.03696
15. Takashima Y, Era T, Nakao K, Kondo S, Kasuga M, Smith AG, Nishikawa S, Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007 129 1377 1388. doi: 10.1016/j.cell.2007.04.028
16. Suzuki G, Iyer V, Lee TC, Canty JM Jr, Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium. Circ Res 2011 109 1044 1054. doi: 10.1161/CIRCRESAHA.111.245969
17. Zhang Z, Yang J, Yan W, Li Y, Shen Z, Asahara T, Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J Am Heart Assoc 2016 5. doi: 10.1161/JAHA.115.002856
18. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY, VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 2011 91 402 411. doi: 10.1093/cvr/cvr053
19. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, Zhang J, Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007 13 2063 2071. doi: 10.1089/ten.2006.0013
20. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ, Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004 110 3300 3305. doi: 10.1161/01.CIR.0000147780.30124.CF
21. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003 362 697 703. doi: 10.1016/S0140-6736(03)14232-8
22. Elmadbouh I, Haider HKh, Jiang S, Idris NM, Lu G, Ashraf M, Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007 42 792 803. doi: 10.1016/j.yjmcc.2007.02.001
23. Zuo K, Kuang D, Wang Y, Xia Y, Tong W, Wang X, Chen Y, Duan Y, Wang G, SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration. Sci Rep 2016 6 26812. doi: 10.1038/srep26812
24. Escot S, Blavet C, Härtle S, Duband JL, Fournier-Thibault C, Misregulation of SDF1-CXCR4 signaling impairs early cardiac neural crest cell migration leading to conotruncal defects. Circ Res 2013 113 505 516. doi: 10.1161/CIRCRESAHA.113.301333
25. Ranganath SH, Levy O, Inamdar MS, Karp JM, Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012 10 244 258. doi: 10.1016/j.stem.2012.02.005
26. Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM, Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res 2009 104 1293 1301. doi: 10.1161/CIRCRESAHA.109.197533
27. Alkass K, Panula J, Westman M, Wu TD, Guerquin-Kern JL, Bergmann O, No evidence for cardiomyocyte number expansion in preadolescent mice. Cell 2015 163 1026 1036. doi: 10.1016/j.cell.2015.10.035
28. Ali SR, Hippenmeyer S, Saadat LV, Luo L, Weissman IL, Ardehali R, Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci U S A 2014 111 8850 8855. doi: 10.1073/pnas.1408233111
29. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerquin-Kern JL, Lechene CP, Lee RT, Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013 493 433 436. doi: 10.1038/nature11682
30. Goldstein BJ, Goss GM, Hatzistergos KE, Rangel EB, Seidler B, Saur D, Hare JM, Adult c-Kit(+) progenitor cells are necessary for maintenance and regeneration of olfactory neurons. J Comp Neurol 2015 523 15 31. doi: 10.1002/cne.23653
31. Heger K, Seidler B, Vahl JC, Schwartz C, Kober M, Klein S, Voehringer D, Saur D, Schmidt-Supprian M, CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells. Eur J Immunol 2014 44 296 306. doi: 10.1002/eji.201343731
32. Klein S, Seidler B, Kettenberger A, Sibaev A, Rohn M, Feil R, Allescher HD, Vanderwinden JM, Hofmann F, Schemann M, Rad R, Storr MA, Schmid RM, Schneider G, Saur D, Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity. Nat Commun 2013 4 1630. doi: 10.1038/ncomms2626
33. Hare JM, Fishman JE, Gerstenblith G, Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. JAMA 2012 308 2369 2379. doi: 10.1001/jama.2012.25321
34. Golpanian S, Wolf A, Hatzistergos KE, Hare JM, Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev 2016 96 1127 1168. doi: 10.1152/physrev.00019.2015
35. Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM, Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol 2012 303 H256 H270. doi: 10.1152/ajpheart.00221.2012
36. Lin Z, Pu WT, Strategies for cardiac regeneration and repair. Sci Transl Med 2014 6 239rv1. doi: 10.1126/scitranslmed.3006681
37. Ishikawa K, Fish K, Aguero J, Yaniz-Galende E, Jeong D, Kho C, Tilemann L, Fish L, Liang L, Eltoukhy AA, Anderson DG, Zsebo K, Costa KD, Hajjar RJ, Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine. Circ Heart Fail 2015 8 167 174. doi: 10.1161/CIRCHEARTFAILURE.114.001711
38. Goichberg P, Bai Y, D'Amario D, The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res 2011 108 1071 1083. doi: 10.1161/CIRCRESAHA.110.239459
39. Goichberg P, Kannappan R, Cimini M, Bai Y, Sanada F, Sorrentino A, Signore S, Kajstura J, Rota M, Anversa P, Leri A, Age-Associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells. Circulation 2013 128 2211 2223. doi: 10.1161/CIRCULATIONAHA.113.004698
40. Nguyen TM, Arthur A, Gronthos S, The role of Eph/ephrin molecules in stromal-hematopoietic interactions. Int J Hematol 2016 103 145 154. doi: 10.1007/s12185-015-1886-x
41. Kirby ML, Hutson MR, Factors controlling cardiac neural crest cell migration. Cell Adh Migr 2010 4 609 621
42. Bergmann O, Zdunek S, Felker A, Dynamics of cell generation and turnover in the human heart. Cell 2015 161 1566 1575. doi: 10.1016/j.cell.2015.05.026
43. van Berlo JH, Molkentin JD, Most of the dust has settled: cKit+ progenitor cells are an irrelevant source of cardiac myocytes in vivo. Circ Res 2016 118 17 19. doi: 10.1161/CIRCRESAHA.115.307934
44. Zaruba MM, Soonpaa M, Reuter S, Field LJ, Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 2010 121 1992 2000. doi: 10.1161/CIRCULATIONAHA.109.909093
45. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J, Fisher PJ, Steffey M, Hesse M, Doran RM, Woods A, Singh B, Yen A, Fleischmann BK, Kotlikoff MI, c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci U S A 2009 106 1808 1813. doi: 10.1073/pnas.0808920106
46. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, Orkin SH, Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006 127 1137 1150. doi: 10.1016/j.cell.2006.10.028